Mathew Jones

557 total citations
13 papers, 109 citations indexed

About

Mathew Jones is a scholar working on Neurology, Epidemiology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Mathew Jones has authored 13 papers receiving a total of 109 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Neurology, 4 papers in Epidemiology and 3 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Mathew Jones's work include Atrial Fibrillation Management and Outcomes (2 papers), Diabetes Management and Research (2 papers) and Epilepsy research and treatment (2 papers). Mathew Jones is often cited by papers focused on Atrial Fibrillation Management and Outcomes (2 papers), Diabetes Management and Research (2 papers) and Epilepsy research and treatment (2 papers). Mathew Jones collaborates with scholars based in United States. Mathew Jones's co-authors include Zachary Smith, Austin Morrison, Mayur Ramesh, Michael A. Peters, Amit Vahia, Jennifer Swiderek, Joseph M. Johnson, Kristin Griebe, Nicole R. Pinelli and Kathie L. Hermayer and has published in prestigious journals such as Neurology, Current Pharmaceutical Design and Journal of Autoimmunity.

In The Last Decade

Mathew Jones

13 papers receiving 107 citations

Peers

Mathew Jones
Preethi William United States
Edoardo Pancaldi Italy
Xavier Fonseca Fuentes United States
Guochao Zhu China
Yu Kasamatsu Japan
Robin Jacob United States
Renata Moll‐Bernardes Brazil
Rozita Khodashahi Iran
Marco Schiuma Italy
А. И. Тарзиманова Russia
Preethi William United States
Mathew Jones
Citations per year, relative to Mathew Jones Mathew Jones (= 1×) peers Preethi William

Countries citing papers authored by Mathew Jones

Since Specialization
Citations

This map shows the geographic impact of Mathew Jones's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mathew Jones with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mathew Jones more than expected).

Fields of papers citing papers by Mathew Jones

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mathew Jones. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mathew Jones. The network helps show where Mathew Jones may publish in the future.

Co-authorship network of co-authors of Mathew Jones

This figure shows the co-authorship network connecting the top 25 collaborators of Mathew Jones. A scholar is included among the top collaborators of Mathew Jones based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mathew Jones. Mathew Jones is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Kalus, James S., et al.. (2023). Deterioration free discharge comparison of andexanet-alfa and prothrombin complex concentrates (PCC) for reversal of factor Xa inhibitor associated bleeds. Journal of Thrombosis and Thrombolysis. 56(2). 315–322. 8 indexed citations
2.
Griebe, Kristin, Mathew Jones, Michael A. Peters, et al.. (2022). Evaluating the impact of severe sepsis 3‐hour bundle compliance on 28‐day in‐hospital mortality: A propensity adjusted, nested case–control study. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 42(8). 651–658. 2 indexed citations
3.
Morrison, Austin, Mathew Jones, Linoj Samuel, et al.. (2021). Evaluation of the selection of cerebrospinal fluid testing in suspected meningitis and encephalitis. Diagnostic Microbiology and Infectious Disease. 102(1). 115571–115571. 4 indexed citations
4.
Morrison, Austin, Joseph M. Johnson, Kristin Griebe, et al.. (2020). Clinical characteristics and predictors of survival in adults with coronavirus disease 2019 receiving tocilizumab. Journal of Autoimmunity. 114. 102512–102512. 56 indexed citations
5.
Varelas, Panayiotis N. & Mathew Jones. (2017). Antiepileptic Drugs in the Neurosurgical Intensive Care. Current Pharmaceutical Design. 23(42). 6533–6550. 2 indexed citations
6.
Jones, Mathew, et al.. (2016). Critical Care Glucose Point-of-Care Testing. Advances in clinical chemistry. 76. 97–121. 10 indexed citations
7.
Mehta, Chandan, et al.. (2016). Intracranial Hemorrhage on Warfarin: Time to Reversal Is of the Essence (I6.004). Neurology. 86(16_supplement). 1 indexed citations
8.
Mehta, Chandan, et al.. (2015). Use of Intrathecal Antibiotic Administration for Treatment of CNS Infections in a Neuro-ICU: A Case Series (P6.033). Neurology. 84(14_supplement). 1 indexed citations
9.
Jones, Mathew, et al.. (2015). Indomethacin for treatment of refractory intracranial hypertension secondary to acute liver failure. American Journal of Health-System Pharmacy. 72(12). 1020–1025. 2 indexed citations
10.
Jennings, Douglas L., Mathew Jones, & David E. Lanfear. (2012). Assessment of the Heart Failure Pharmacotherapy of Patients with Continuous Flow Left-Ventricular Assist Devices. The International Journal of Artificial Organs. 35(3). 177–179. 7 indexed citations
11.
Pinelli, Nicole R., et al.. (2011). Exogenous Glucagon-Like Peptide-1 for Hyperglycemia in Critically Ill Patients. Annals of Pharmacotherapy. 46(1). 124–129. 13 indexed citations
12.
13.
Ellison, Patricia H., et al.. (1986). The Results of Checking a Scoring System for Neonatal Seizures1. Neuropediatrics. 17(3). 152–157. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Preethi William Breakdown of academic impact, for papers by Edoardo Pancaldi Breakdown of academic impact, for papers by Xavier Fonseca Fuentes Breakdown of academic impact, for papers by Guochao Zhu Breakdown of academic impact, for papers by Yu Kasamatsu Breakdown of academic impact, for papers by Robin Jacob Breakdown of academic impact, for papers by Renata Moll‐Bernardes Breakdown of academic impact, for papers by Rozita Khodashahi Breakdown of academic impact, for papers by Marco Schiuma Breakdown of academic impact, for papers by А. И. Тарзиманова
Rankless by CCL
2026